SCHEMBL7197301

SCHEMBL7197301

C=CCOc1ccc(C(=O)C=Cc2cc(OC)c(CCCCCC)c(OC)c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.56
LMNA P02545 2/20 0.56
MAPT P10636 2/20 0.56
ALDH1A1 P00352 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
PTPN1 P18031 7/20 0.53
KRAS P01116 1/20 0.50
EGFR P00533 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC2 Q92769 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
ABCG2 Q9UNQ0 1/20 0.48
DPP4 P27487 1/20 0.48
FLT3 P36888 1/20 0.47
MAOB P27338 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
TNFRSF1A P19438 1/20 0.47
SLC5A1 P13866 1/20 0.47
SLC5A2 P31639 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7197297 1.00 KDM4E (0.56) KDM4ELMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL7196525 0.96 KDM4E (0.58) KDM4ELMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL7196528 0.96 KDM4E (0.58) KDM4ELMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL9113065 0.92 KDM4E (0.60) KDM4ELMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL9113073 0.92 KDM4E (0.60) KDM4ELMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL9113828 0.87 ABCG2 (0.54) KDM4ELMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL9113961 0.85 PTPN1 (0.64) KDM4ELMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL9113968 0.85 PTPN1 (0.64) KDM4ELMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL7194628 0.85 KDM4E (0.62) KDM4ELMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL7194631 0.85 KDM4E (0.62) KDM4ELMNAMAPTALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030065039-A1 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones STATENS SERUM INSTITUTE (DK) 2003-04-03 US disclosed
EP-0996432-A2 BIOLOGICALLY ACTIVE 1,3-BIS-AROMATIC-PROP-2-EN-1-ONES, 1,3-BIS-AROMATIC-PROPAN-1-ONES, AND 1,3-BIS-AROMATIC-PROP-2-YN-1-ONES STATENS SERUMINSTITUT (DK) 2000-05-03 EP disclosed
WO-1999000114-A2 BIOLOGICALLY ACTIVE 1,3-BIS-AROMATIC-PROP-2-EN-1-ONES, 1,3-BIS-AROMATIC-PROPAN-1-ONES, AND 1,3-BIS-AROMATIC-PROP-2-YN-1-ONES STATENS SERUM INSTITUT (DK) 1999-01-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065039-A1 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones AKR1C3, AKR1C1, AKR1A1 KDM4E 1204/4885LMNA 1586/4885MAPT 3817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.